Invanz

Active Ingredient(s): Ertapenem
FDA Approved: * November 21, 2001
Pharm Company: * MERCK
Category: Antibiotics

Ertapenem (trade name Invanz) is a carbapenem antibiotic medication for the treatment of infections of the abdomen, the lungs, the upper part of the female reproductive system, and diabetic foot, used in the form of infusions or injections.[6][7] The most common side effects include diarrhoea, nausea (feeling sick), headache, and problems around the area where the medicine is infused. It can significantly reduce the concentrations of valproic acid, an anti-seiz... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
5 Discussions